Elsharawy KA - Search Results

1

Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer.

Kariri YA, Joseph C, Alsaleem MA, Elsharawy KA, Alsaeed S, Toss MS, Mongan NP, Green AR, Rakha EA. Kariri YA, et al. Among authors: elsharawy ka. Cancers (Basel). 2022 Nov 17;14(22):5643. doi: 10.3390/cancers14225643. Cancers (Basel). 2022. PMID: 36428736 Free PMC article.

2

Upregulation of Cyclin B2 (CCNB2) in breast cancer contributes to the development of lymphovascular invasion.

Aljohani AI, Toss MS, El-Sharawy KA, Mirza S, Ball GR, Green AR, Rakha EA. Aljohani AI, et al. Am J Cancer Res. 2022 Feb 15;12(2):469-489. eCollection 2022. Am J Cancer Res. 2022. PMID: 35261781 Free PMC article.

3

Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer.

Kariri Y, Toss MS, Alsaleem M, Elsharawy KA, Joseph C, Mongan NP, Green AR, Rakha EA. Kariri Y, et al. Among authors: elsharawy ka. Breast Cancer Res Treat. 2022 Apr;192(3):529-539. doi: 10.1007/s10549-022-06531-5. Epub 2022 Feb 6. Breast Cancer Res Treat. 2022. PMID: 35124721 Free PMC article.

4

Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer.

Althobiti M, El-Sharawy KA, Joseph C, Aleskandarany M, Toss MS, Green AR, Rakha EA. Althobiti M, et al. Breast Cancer Res Treat. 2021 Oct;189(3):621-630. doi: 10.1007/s10549-021-06336-y. Epub 2021 Aug 28. Breast Cancer Res Treat. 2021. PMID: 34453638 Free PMC article.

5

Artificial intelligence grading of breast cancer: a promising method to refine prognostic classification for management precision.

Elsharawy KA, Gerds TA, Rakha EA, Dalton LW. Elsharawy KA, et al. Histopathology. 2021 Aug;79(2):187-199. doi: 10.1111/his.14354. Epub 2021 May 6. Histopathology. 2021. PMID: 33590486

6

Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer.

Elsharawy KA, Althobiti M, Mohammed OJ, Aljohani AI, Toss MS, Green AR, Rakha EA. Elsharawy KA, et al. Breast Cancer Res Treat. 2021 Feb;185(3):615-627. doi: 10.1007/s10549-020-05999-3. Epub 2020 Nov 8. Breast Cancer Res Treat. 2021. PMID: 33161513 Free PMC article.

7

The nucleolar-related protein Dyskerin pseudouridine synthase 1 (DKC1) predicts poor prognosis in breast cancer.

Elsharawy KA, Mohammed OJ, Aleskandarany MA, Hyder A, El-Gammal HL, Abou-Dobara MI, Green AR, Dalton LW, Rakha EA. Elsharawy KA, et al. Br J Cancer. 2020 Nov;123(10):1543-1552. doi: 10.1038/s41416-020-01045-7. Epub 2020 Sep 1. Br J Cancer. 2020. PMID: 32868896 Free PMC article.

8

Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study.

Rakha EA, Alsaleem M, ElSharawy KA, Toss MS, Raafat S, Mihai R, Minhas FA, Green AR, Rajpoot NM, Dalton LW, Mongan NP. Rakha EA, et al. Among authors: elsharawy ka. Histopathology. 2020 Oct;77(4):631-645. doi: 10.1111/his.14199. Epub 2020 Sep 1. Histopathology. 2020. PMID: 32618014

9

Prognostic significance of nucleolar assessment in invasive breast cancer.

Elsharawy KA, Toss MS, Raafat S, Ball G, Green AR, Aleskandarany MA, Dalton LW, Rakha EA. Elsharawy KA, et al. Histopathology. 2020 Apr;76(5):671-684. doi: 10.1111/his.14036. Epub 2020 Mar 26. Histopathology. 2020. PMID: 31736094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters